Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Tyro3 family-mediated cell entry of Ebola and Marburg viruses.

Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y.

J Virol. 2006 Oct;80(20):10109-16.

2.

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses.

Chan SY, Empig CJ, Welte FJ, Speck RF, Schmaljohn A, Kreisberg JF, Goldsmith MA.

Cell. 2001 Jul 13;106(1):117-26.

3.

Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor.

Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, Vincent MJ, Towner JS, Nichol ST, Bavari S, Choe H, Aman MJ, Farzan M.

J Biol Chem. 2006 Jun 9;281(23):15951-8. Epub 2006 Apr 4.

4.

Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.

Kuroda M, Fujikura D, Nanbo A, Marzi A, Noyori O, Kajihara M, Maruyama J, Matsuno K, Miyamoto H, Yoshida R, Feldmann H, Takada A.

J Virol. 2015 Jun;89(12):6481-93. doi: 10.1128/JVI.03156-14. Epub 2015 Apr 8.

5.

Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.

Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.

J Virol. 2011 Sep;85(17):8502-13. doi: 10.1128/JVI.02600-10. Epub 2011 Jun 22.

6.

The mechanism of Axl-mediated Ebola virus infection.

Shimojima M, Ikeda Y, Kawaoka Y.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S259-63.

PMID:
17940958
7.

Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses.

Chan SY, Speck RF, Ma MC, Goldsmith MA.

J Virol. 2000 May;74(10):4933-7.

8.

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.

Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ.

J Exp Med. 2002 Mar 4;195(5):593-602.

9.

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.

Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L.

J Virol. 2015 Oct;89(19):9932-8. doi: 10.1128/JVI.01337-15. Epub 2015 Jul 22.

10.

Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.

O'Hearn A, Wang M, Cheng H, Lear-Rooney CM, Koning K, Rumschlag-Booms E, Varhegyi E, Olinger G, Rong L.

J Virol. 2015 May;89(10):5441-9. doi: 10.1128/JVI.03689-14. Epub 2015 Mar 4.

11.

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.

Geisbert TW, Geisbert JB, Leung A, Daddario-DiCaprio KM, Hensley LE, Grolla A, Feldmann H.

J Virol. 2009 Jul;83(14):7296-304. doi: 10.1128/JVI.00561-09. Epub 2009 Apr 22.

12.

Infection and activation of monocytes by Marburg and Ebola viruses.

Ströher U, West E, Bugany H, Klenk HD, Schnittler HJ, Feldmann H.

J Virol. 2001 Nov;75(22):11025-33.

13.

Filovirus entry: a novelty in the viral fusion world.

Hunt CL, Lennemann NJ, Maury W.

Viruses. 2012 Feb;4(2):258-75. doi: 10.3390/v4020258. Epub 2012 Feb 7. Review.

14.

The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.

Hunt CL, Kolokoltsov AA, Davey RA, Maury W.

J Virol. 2011 Jan;85(1):334-47. doi: 10.1128/JVI.01278-09. Epub 2010 Nov 3.

15.

Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences.

Carroll SA, Towner JS, Sealy TK, McMullan LK, Khristova ML, Burt FJ, Swanepoel R, Rollin PE, Nichol ST.

J Virol. 2013 Mar;87(5):2608-16. doi: 10.1128/JVI.03118-12. Epub 2012 Dec 19.

16.

Innate immune evasion by filoviruses.

Basler CF.

Virology. 2015 May;479-480:122-30. doi: 10.1016/j.virol.2015.03.030. Epub 2015 Apr 3. Review.

17.

[Feline immunodeficiency virus tropism].

Shimojima M.

Uirusu. 2007 Jun;57(1):75-82. Review. Japanese.

18.

Development of treatment strategies to combat Ebola and Marburg viruses.

Paragas J, Geisbert TW.

Expert Rev Anti Infect Ther. 2006 Feb;4(1):67-76. Review.

PMID:
16441210
19.

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.

Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S.

Vaccine. 2005 Apr 27;23(23):3033-42.

PMID:
15811650
20.

Development of high-content imaging assays for lethal viral pathogens.

Panchal RG, Kota KP, Spurgers KB, Ruthel G, Tran JP, Boltz RC, Bavari S.

J Biomol Screen. 2010 Aug;15(7):755-65. doi: 10.1177/1087057110374357. Epub 2010 Jul 16.

PMID:
20639507

Supplemental Content

Support Center